Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Overview of Key Overnight Developments on August 8

Overview of Key Overnight Developments on August 8

金色财经金色财经2025/08/07 23:37
Show original

21:00 (UTC+8) - 7:00 Keywords: Paxos, Chainlink, Scenius Capital, Stephen Moore 1. Chainlink will use protocol revenue to build a LINK reserve; 2. Trump announces the nomination of Stephen Moore as a Federal Reserve Board member; 3. Sources: Waller emerges as a leading candidate for the new Federal Reserve Chair; 4. Trump signs executive order to halt the crypto industry's "de-banking"; 5. Paxos reaches a $48.5 million settlement agreement with New York financial regulators; 6. Trump signs executive order allowing 401(k) retirement plans to invest in cryptocurrencies; 7. Scenius Capital raises $20 million for a crypto venture capital fund; 8. The legal dispute between the SEC and Ripple officially ends, with the ruling that XRP is not a security taking final effect.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Competition in US oral weight-loss drugs intensifies! Eli Lilly (LLY.US) Foundayo captures 30% of new patients, narrowing Novo Nordisk's (NVO.US) first-mover advantage

Eli Lilly stated on Monday that its oral weight-loss drug, Foundayo, has captured over 30% of the market share among new patients in the US oral obesity treatment market, narrowing the early lead achieved by Danish competitor Novo Nordisk with its Wegovy oral tablets.

智通财经2026/09/15 03:21
Competition in US oral weight-loss drugs intensifies! Eli Lilly (LLY.US) Foundayo captures 30% of new patients, narrowing Novo Nordisk's (NVO.US) first-mover advantage